Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
Form 144 filed for ORA (Ormat Technologies, Inc.) reporting a proposed sale of common stock by an insider. The notice lists 9,343 shares offered for sale through Morgan Stanley Smith Barney LLC with an aggregate market value of $871,810.28 and indicates approximately 60,723,470 shares outstanding. The filing details that the securities were acquired mostly as restricted stock and performance shares on various dates from 2023 to 2025. The filer also reported a sale on 08/22/2025 of 7,066 shares generating $669,220.86 in gross proceeds. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Orm at Technologies insider sale disclosure: Director Stanley Stern sold 876 shares of ORA common stock in the open market on 08/27/2025 at a reported price of $91.985 per share. After the sale, the reporting person beneficially owned 5,261 shares, held directly. The Form 4 was filed by an attorney-in-fact (/s/ Jessica Woelfel) on 08/29/2025. The filing is a routine Section 16 disclosure of a single non-derivative disposition and does not include any derivatives, amendments, or additional transactions.
Form 144 for Ormat Technologies, Inc. (ORA) shows a proposed sale of 876 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $80,578.86 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock on 05/08/2025 from the issuer and paid for on that date. The filing notes 60,723,470 shares outstanding for the class. It also reports a prior sale by the same account: 547 shares sold on 06/20/2025 for gross proceeds of $46,791.58. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Ormat Technologies insider Assi Ginzburg exercised all 25,524 Stock Appreciation Rights (SARs) granted May 12, 2020 and expiring May 12, 2026 on 08/22/2025. The filing shows 18,458 shares were delivered to the issuer to cover the exercise price and 7,066 shares were sold in the open market at $94.71 per share. The SAR conversion price recorded is $68.34. The Form 4 lists post-transaction beneficial ownership figures of 59,349, 40,891, and 33,825 shares on the respective table lines.
Jessica Woelfel, who serves as General Counsel, Chief Compliance Officer and Corporate Secretary of Ormat Technologies, Inc. (ORA), reported the sale of 692 shares of the company’s common stock in the open market on August 22, 2025 at a reported price of $94.57 per share. Following this transaction she beneficially owned 5,234 shares, held directly.
The filing is a routine Section 16 Form 4 disclosure showing an officer and director reducing a direct holding. The document contains no other transactions, derivative activity, compensation details or narrative explaining the sale.
Ormat Technologies director David Granot exercised 1,210 Stock Appreciation Rights (SARs) on 08/21/2025 that expire on November 6, 2025. Upon exercise he transferred 1,011 shares back to the issuer to cover the exercise price and sold the remaining 199 shares in the open market. The SARs had a grant price of $76.87; the reported sale prices for disposed shares were $92.435 and $92.44. After these transactions Granot beneficially owned 2,579 shares of ORA common stock. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
Ormat Technologies, Inc. (ORA) submitted a Form 144 notice indicating a proposed sale of 7,066 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $669,220.86. The filing lists total shares outstanding as 60,723,470 and an approximate sale date of 08/22/2025.
The securities were acquired on 08/22/2025 via Stock Appreciation Rights from the issuer and payment is listed as cash on the same date. The filer reports no securities sold in the past three months. Several standard filer identification fields are blank in the provided text.
Ormat Technologies, Inc. (ORA) Form 144 notice reports a proposed sale of 692 common shares by an affiliate through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $65,442.44. The shares were acquired as performance shares on 03/01/2025 from the issuer, with acquisition and payment dated the same day. The filer has disclosed two prior sales by the same person on 06/18/2025 totaling 564 shares for gross proceeds of $47,187.00. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Ormat Technologies, Inc. (ORA) filing a Form 144 notifies the planned sale of 199 common shares through Morgan Stanley Smith Barney with an aggregate market value of $18,394.55, with an approximate sale date of 08/21/2025 on the NYSE. The filing states these shares were acquired on 08/21/2025 as Stock Appreciation Rights and the reported method of payment was cash.
The filer also disclosed prior sales by the same person: two transactions on 06/18/2025 totaling 1,072 shares with gross proceeds of $91,120.00. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Ormat Technologies insider activity: Director Byron G. Wong exercised Stock Appreciation Rights (SARs) on 08/18/2025. He exercised 1,210 SARs expiring 11/06/2025 and 1,315 SARs expiring 11/04/2026. From the first exercise he received 1,210 shares, surrendered 1,018 shares to cover the exercise price and sold 192 shares in the open market at $91.395 per share. From the second exercise he received 1,315 shares, surrendered 972 shares and sold 343 shares at $91.395. The SAR grant prices were $76.87 and $67.54.